Metabolic Signatures of Tumor Responses to Doxorubicin Elucidated by Metabolic Profiling in Ovo.

Iman W AchkarSara KaderShaima S DibKulsoom JunejoSalha Bujassoum Al-BaderShahina HayatAditya M BhagwatXavier RoussetYan WangJean VialletKarsten SuhreAnna Halama

Published in: Metabolites (2020)

Metabolomics in combination with in ovo tumor models provide a robust platform for drug testing to reveal tumor specific treatment targets such as the antioxidative tumor capacity.

Keyphrases

genome wide
gene expression
emergency department
mass spectrometry
high throughput
dna methylation
adverse drug